Search

Your search keyword '"Erythropoietin/*therapeutic use"' showing total 34 results

Search Constraints

Start Over You searched for: Descriptor "Erythropoietin/*therapeutic use" Remove constraint Descriptor: "Erythropoietin/*therapeutic use" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
34 results on '"Erythropoietin/*therapeutic use"'

Search Results

1. Iron Deficiency in Heart Failure and Effect of Dapagliflozin : Findings From DAPA-HF.

2. Erytropoietin som mulig behandling ved hjernesygdom

3. Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants

4. Switch From Conventional to Every Other Day Hemodialysis: A Comparison Pilot Study

5. Phase I Trial of Intravenous Cisplatin-Topotecan Chemotherapy for Three Consecutive Days in Patients with Advanced Solid Tumors: Parallel Topotecan Escalation in Two Fixed Platinum Dosing Schemes

6. Alterations in body weight, breaking strength, and wound healing in Wistar rats treated pre- and postoperatively with erythropoietin or granulocyte macrophage–colony stimulating factor: Evidence of a previously unknown anabolic effect of erythropoietin?

7. Ferric carboxymaltose increases epoetin-alpha response and prevents iron deficiency before elective orthopaedic surgery

8. Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients

9. Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance

10. The role of erythropoietin in central and peripheral nerve injury

11. Axonal regeneration stimulated by erythropoietin: an experimental study in rats

12. Role of Gas6 in erythropoiesis and anemia in mice

13. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model

14. External radiotherapy and anaemia treatment: state of the art

15. Recombinant human erythropoietin in a triplet pregnancy: a case report

16. Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome

17. Antierythropoietin antibodies in thalassemia patients

18. Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human erythropoietin (rHuEPO): A prospective, open label, randomized trial by the hellenic cooperative oncology group

19. Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients

20. Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes

21. Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromes

22. Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient

23. Effective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case report

24. Effect of recombinant human erythropoietin in preterm infants

25. Recombinant human erythropoietin treatment of postpartum anemia. Preliminary results

26. Recombinant human erythropoietin for the treatment of refractory anemia in lymphoproliferative disorders: preliminary results

27. Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis

28. Combination therapy with recombinant human erythropoietin, interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in idiopathic myelofibrosis

29. Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy

31. Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure

32. Murine autoimmune hemolytic anemia resulting from Fc gamma receptor-mediated erythrophagocytosis: protection by erythropoietin but not by interleukin-3, and aggravation by granulocyte-macrophage colony-stimulating factor

33. Interleukin 3 perfusion prevents death due to acute anemia induced by monoclonal antierythrocyte autoantibody

34. Treatment of MDS patients with recombinant human erythropoietin and the role of GSTs

Catalog

Books, media, physical & digital resources